Showing results (2001-2010 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 22, 2014
Challenges in modelling the cost effectiveness of various interventions for cardiovascular diseaseLaura T Burgers, William K Redekop, Johan L SeverensPharmacoeconomics|March 15, 2014
When to use discrete event simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DESJonathan Karnon, Hossein Haji Ali AfzaliPharmacoeconomics|January 8, 2017
Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score DataJason Madan, Kamran A Khan, Stavros Petrou, et al.Pharmacoeconomics|January 8, 2017
Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature ReviewMelina Dritsaki, Felix Achana, James Mason, et al.Pharmacoeconomics|December 13, 2016
Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and MedicineMike Paulden, James F O'Mahony, Christopher McCabePharmacoeconomics|May 8, 2014
Barriers to the uptake of biosimilars and possible solutions: a Belgian case studyPieter Dylst, Arnold Vulto, Steven SimoensPharmacoeconomics|October 19, 2016
Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes MellitusAsrul Akmal Shafie, Chin Hui Ng, Yui Ping Tan, et al.Pharmacoeconomics|October 19, 2016
Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology AppraisalIrina A Tikhonova, Martin W Hoyle, Tristan M Snowsill, et al.Pharmacoeconomics|February 11, 2017
Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic ReviewJames Brockbank, Sorrel WolowaczPharmacoeconomics|August 12, 2003
Integer/linear mathematical programming models: a tool for allocating healthcare resourcesStephanie R Earnshaw, Susan L DennettPageof 336